nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Glyburide—gestational diabetes	0.386	0.417	CbGbCtD
Buprenorphine—CYP2C19—Glyburide—gestational diabetes	0.172	0.187	CbGbCtD
Buprenorphine—CYP2C9—Glyburide—gestational diabetes	0.143	0.155	CbGbCtD
Buprenorphine—ABCB1—Glyburide—gestational diabetes	0.139	0.151	CbGbCtD
Buprenorphine—CYP3A4—Glyburide—gestational diabetes	0.0833	0.0902	CbGbCtD
Buprenorphine—Heartburn—Glyburide—gestational diabetes	0.00265	0.0946	CcSEcCtD
Buprenorphine—UGT1A9—Phase II conjugation—GGCT—gestational diabetes	0.00146	0.03	CbGpPWpGaD
Buprenorphine—Visual disturbance—Glyburide—gestational diabetes	0.0014	0.0499	CcSEcCtD
Buprenorphine—Diplopia—Glyburide—gestational diabetes	0.00132	0.0473	CcSEcCtD
Buprenorphine—OPRL1—Circadian rythm related genes—MTNR1B—gestational diabetes	0.00127	0.0262	CbGpPWpGaD
Buprenorphine—Abdominal distension—Glyburide—gestational diabetes	0.00115	0.0411	CcSEcCtD
Buprenorphine—OPRL1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00112	0.0231	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—NAMPT—gestational diabetes	0.00111	0.0229	CbGpPWpGaD
Buprenorphine—CYP2C18—FOXA1 transcription factor network—AR—gestational diabetes	0.00108	0.0224	CbGpPWpGaD
Buprenorphine—CYP2C18—Biological oxidations—GGCT—gestational diabetes	0.00108	0.0222	CbGpPWpGaD
Buprenorphine—CYP2C18—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00108	0.0222	CbGpPWpGaD
Buprenorphine—OPRL1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00104	0.0215	CbGpPWpGaD
Buprenorphine—OPRL1—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.00091	0.0188	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000893	0.0184	CbGpPWpGaD
Buprenorphine—Visual impairment—Glyburide—gestational diabetes	0.000883	0.0315	CcSEcCtD
Buprenorphine—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00087	0.0179	CbGpPWpGaD
Buprenorphine—CYP2C18—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000859	0.0177	CbGpPWpGaD
Buprenorphine—Eye disorder—Glyburide—gestational diabetes	0.000856	0.0306	CcSEcCtD
Buprenorphine—UGT1A9—Biological oxidations—GGCT—gestational diabetes	0.000851	0.0175	CbGpPWpGaD
Buprenorphine—Erythema—Glyburide—gestational diabetes	0.000797	0.0285	CcSEcCtD
Buprenorphine—Malnutrition—Glyburide—gestational diabetes	0.000797	0.0285	CcSEcCtD
Buprenorphine—Vision blurred—Glyburide—gestational diabetes	0.000752	0.0268	CcSEcCtD
Buprenorphine—Tremor—Glyburide—gestational diabetes	0.000747	0.0267	CcSEcCtD
Buprenorphine—ABCG2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.00074	0.0152	CbGpPWpGaD
Buprenorphine—Angioedema—Glyburide—gestational diabetes	0.000729	0.026	CcSEcCtD
Buprenorphine—CYP3A7—Biological oxidations—GGCT—gestational diabetes	0.000716	0.0148	CbGpPWpGaD
Buprenorphine—CYP2C18—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000705	0.0145	CbGpPWpGaD
Buprenorphine—Convulsion—Glyburide—gestational diabetes	0.000691	0.0247	CcSEcCtD
Buprenorphine—OPRL1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00068	0.014	CbGpPWpGaD
Buprenorphine—Myalgia—Glyburide—gestational diabetes	0.000679	0.0242	CcSEcCtD
Buprenorphine—Arthralgia—Glyburide—gestational diabetes	0.000679	0.0242	CcSEcCtD
Buprenorphine—CYP2A6—Biological oxidations—GGCT—gestational diabetes	0.000656	0.0135	CbGpPWpGaD
Buprenorphine—Confusional state—Glyburide—gestational diabetes	0.000656	0.0234	CcSEcCtD
Buprenorphine—Oedema—Glyburide—gestational diabetes	0.000651	0.0232	CcSEcCtD
Buprenorphine—Shock—Glyburide—gestational diabetes	0.00064	0.0229	CcSEcCtD
Buprenorphine—Nervous system disorder—Glyburide—gestational diabetes	0.000638	0.0228	CcSEcCtD
Buprenorphine—Hyperhidrosis—Glyburide—gestational diabetes	0.000629	0.0225	CcSEcCtD
Buprenorphine—Anorexia—Glyburide—gestational diabetes	0.00062	0.0221	CcSEcCtD
Buprenorphine—Hypotension—Glyburide—gestational diabetes	0.000608	0.0217	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000593	0.0212	CcSEcCtD
Buprenorphine—Paraesthesia—Glyburide—gestational diabetes	0.000584	0.0209	CcSEcCtD
Buprenorphine—Dyspnoea—Glyburide—gestational diabetes	0.00058	0.0207	CcSEcCtD
Buprenorphine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000579	0.0119	CbGpPWpGaD
Buprenorphine—Dyspepsia—Glyburide—gestational diabetes	0.000573	0.0204	CcSEcCtD
Buprenorphine—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000571	0.0118	CbGpPWpGaD
Buprenorphine—Decreased appetite—Glyburide—gestational diabetes	0.000566	0.0202	CcSEcCtD
Buprenorphine—OPRL1—Circadian rythm related genes—LEP—gestational diabetes	0.000566	0.0117	CbGpPWpGaD
Buprenorphine—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000562	0.0201	CcSEcCtD
Buprenorphine—Feeling abnormal—Glyburide—gestational diabetes	0.000536	0.0191	CcSEcCtD
Buprenorphine—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000533	0.011	CbGpPWpGaD
Buprenorphine—Gastrointestinal pain—Glyburide—gestational diabetes	0.000532	0.019	CcSEcCtD
Buprenorphine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00053	0.0109	CbGpPWpGaD
Buprenorphine—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000523	0.0108	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—GGCT—gestational diabetes	0.000518	0.0107	CbGpPWpGaD
Buprenorphine—Urticaria—Glyburide—gestational diabetes	0.000517	0.0185	CcSEcCtD
Buprenorphine—Abdominal pain—Glyburide—gestational diabetes	0.000514	0.0184	CcSEcCtD
Buprenorphine—OPRK1—Mecp2 and Associated Rett Syndrome—FGF2—gestational diabetes	0.000506	0.0104	CbGpPWpGaD
Buprenorphine—Hypersensitivity—Glyburide—gestational diabetes	0.000479	0.0171	CcSEcCtD
Buprenorphine—OPRD1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000479	0.00988	CbGpPWpGaD
Buprenorphine—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000469	0.00967	CbGpPWpGaD
Buprenorphine—Asthenia—Glyburide—gestational diabetes	0.000467	0.0167	CcSEcCtD
Buprenorphine—Pruritus—Glyburide—gestational diabetes	0.00046	0.0164	CcSEcCtD
Buprenorphine—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.000448	0.00924	CbGpPWpGaD
Buprenorphine—Diarrhoea—Glyburide—gestational diabetes	0.000445	0.0159	CcSEcCtD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000445	0.00917	CbGpPWpGaD
Buprenorphine—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00043	0.00886	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00042	0.00866	CbGpPWpGaD
Buprenorphine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000418	0.00862	CbGpPWpGaD
Buprenorphine—Vomiting—Glyburide—gestational diabetes	0.000414	0.0148	CcSEcCtD
Buprenorphine—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000413	0.00851	CbGpPWpGaD
Buprenorphine—Rash—Glyburide—gestational diabetes	0.00041	0.0146	CcSEcCtD
Buprenorphine—Dermatitis—Glyburide—gestational diabetes	0.00041	0.0146	CcSEcCtD
Buprenorphine—Headache—Glyburide—gestational diabetes	0.000408	0.0146	CcSEcCtD
Buprenorphine—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.0004	0.00825	CbGpPWpGaD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.0004	0.00824	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00039	0.00804	CbGpPWpGaD
Buprenorphine—Nausea—Glyburide—gestational diabetes	0.000387	0.0138	CcSEcCtD
Buprenorphine—OPRL1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000384	0.00792	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000381	0.00786	CbGpPWpGaD
Buprenorphine—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000378	0.0078	CbGpPWpGaD
Buprenorphine—CYP2C18—Biological oxidations—CYP19A1—gestational diabetes	0.000375	0.00772	CbGpPWpGaD
Buprenorphine—CYP2C18—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00037	0.00762	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000368	0.00758	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000365	0.00752	CbGpPWpGaD
Buprenorphine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000362	0.00746	CbGpPWpGaD
Buprenorphine—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000357	0.00737	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000355	0.00732	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000349	0.00719	CbGpPWpGaD
Buprenorphine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000339	0.00699	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000334	0.00689	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00033	0.0068	CbGpPWpGaD
Buprenorphine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000323	0.00666	CbGpPWpGaD
Buprenorphine—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000319	0.00658	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000312	0.00642	CbGpPWpGaD
Buprenorphine—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000312	0.00642	CbGpPWpGaD
Buprenorphine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000297	0.00613	CbGpPWpGaD
Buprenorphine—UGT1A9—Biological oxidations—CYP19A1—gestational diabetes	0.000296	0.0061	CbGpPWpGaD
Buprenorphine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000295	0.00608	CbGpPWpGaD
Buprenorphine—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000294	0.00605	CbGpPWpGaD
Buprenorphine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000293	0.00605	CbGpPWpGaD
Buprenorphine—UGT1A9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000292	0.00602	CbGpPWpGaD
Buprenorphine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000291	0.006	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00029	0.00598	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000283	0.00582	CbGpPWpGaD
Buprenorphine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000275	0.00567	CbGpPWpGaD
Buprenorphine—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000262	0.0054	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—LEPR—gestational diabetes	0.000261	0.00538	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000255	0.00525	CbGpPWpGaD
Buprenorphine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000252	0.00519	CbGpPWpGaD
Buprenorphine—CYP3A7—Biological oxidations—CYP19A1—gestational diabetes	0.000249	0.00513	CbGpPWpGaD
Buprenorphine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000249	0.00512	CbGpPWpGaD
Buprenorphine—CYP3A7—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000246	0.00506	CbGpPWpGaD
Buprenorphine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000241	0.00497	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000241	0.00496	CbGpPWpGaD
Buprenorphine—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00024	0.00496	CbGpPWpGaD
Buprenorphine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000239	0.00493	CbGpPWpGaD
Buprenorphine—CYP2A6—Biological oxidations—CYP19A1—gestational diabetes	0.000228	0.00471	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000215	0.00443	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MTNR1B—gestational diabetes	0.000206	0.00425	CbGpPWpGaD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000205	0.00422	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000204	0.00421	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—RBP4—gestational diabetes	0.000201	0.00414	CbGpPWpGaD
Buprenorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000194	0.00401	CbGpPWpGaD
Buprenorphine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000192	0.00395	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GGCT—gestational diabetes	0.000184	0.0038	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	0.00018	0.00371	CbGpPWpGaD
Buprenorphine—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000178	0.00366	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000164	0.00338	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GLS2—gestational diabetes	0.000161	0.00332	CbGpPWpGaD
Buprenorphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000158	0.00325	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000156	0.00321	CbGpPWpGaD
Buprenorphine—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000154	0.00317	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000149	0.00307	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GGCT—gestational diabetes	0.000146	0.003	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000144	0.00296	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000139	0.00287	CbGpPWpGaD
Buprenorphine—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000137	0.00283	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000131	0.00269	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000128	0.00264	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GLS2—gestational diabetes	0.000127	0.00262	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000127	0.00262	CbGpPWpGaD
Buprenorphine—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000126	0.0026	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000126	0.00259	CbGpPWpGaD
Buprenorphine—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000125	0.00258	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GGCT—gestational diabetes	0.000124	0.00255	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GGCT—gestational diabetes	0.000122	0.00252	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000122	0.00251	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000122	0.00251	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000114	0.00234	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GGCT—gestational diabetes	0.000112	0.00231	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—LEPR—gestational diabetes	0.000111	0.00229	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—MTNR1B—gestational diabetes	0.00011	0.00228	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.000108	0.00224	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GLS2—gestational diabetes	0.000108	0.00223	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GLS2—gestational diabetes	0.000107	0.00221	CbGpPWpGaD
Buprenorphine—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000107	0.0022	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000101	0.00208	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000101	0.00208	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GLS2—gestational diabetes	9.81e-05	0.00202	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LEPR—gestational diabetes	9.76e-05	0.00201	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—LEP—gestational diabetes	9.16e-05	0.00189	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GGCT—gestational diabetes	8.85e-05	0.00182	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NAMPT—gestational diabetes	8.82e-05	0.00182	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MTNR1B—gestational diabetes	8.8e-05	0.00181	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GCK—gestational diabetes	8.76e-05	0.00181	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RBP4—gestational diabetes	8.58e-05	0.00177	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	8.37e-05	0.00173	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	8.26e-05	0.0017	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEPR—gestational diabetes	8.25e-05	0.0017	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TNF—gestational diabetes	8.19e-05	0.00169	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GLS2—gestational diabetes	7.74e-05	0.00159	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MTNR1B—gestational diabetes	7.72e-05	0.00159	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GGCT—gestational diabetes	7.67e-05	0.00158	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RBP4—gestational diabetes	7.52e-05	0.00155	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NAMPT—gestational diabetes	6.97e-05	0.00144	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—FGF2—gestational diabetes	6.96e-05	0.00143	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GCK—gestational diabetes	6.93e-05	0.00143	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GGCT—gestational diabetes	6.84e-05	0.00141	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.79e-05	0.0014	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GLS2—gestational diabetes	6.7e-05	0.00138	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GGCT—gestational diabetes	6.68e-05	0.00138	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	6.64e-05	0.00137	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MTNR1B—gestational diabetes	6.52e-05	0.00134	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CYP19A1—gestational diabetes	6.41e-05	0.00132	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RBP4—gestational diabetes	6.36e-05	0.00131	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GGCT—gestational diabetes	6.29e-05	0.0013	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GGCT—gestational diabetes	6.24e-05	0.00129	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.99e-05	0.00123	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GLS2—gestational diabetes	5.98e-05	0.00123	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NAMPT—gestational diabetes	5.92e-05	0.00122	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GCK—gestational diabetes	5.88e-05	0.00121	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NAMPT—gestational diabetes	5.86e-05	0.00121	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GLS2—gestational diabetes	5.84e-05	0.0012	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GCK—gestational diabetes	5.83e-05	0.0012	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GLS2—gestational diabetes	5.5e-05	0.00113	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GLS2—gestational diabetes	5.45e-05	0.00112	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NAMPT—gestational diabetes	5.37e-05	0.00111	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.35e-05	0.0011	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GCK—gestational diabetes	5.34e-05	0.0011	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GGCT—gestational diabetes	5.33e-05	0.0011	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP19A1—gestational diabetes	5.07e-05	0.00104	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.87e-05	0.001	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GLS2—gestational diabetes	4.66e-05	0.00096	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP19A1—gestational diabetes	4.3e-05	0.000886	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP19A1—gestational diabetes	4.26e-05	0.000878	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NAMPT—gestational diabetes	4.24e-05	0.000874	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GCK—gestational diabetes	4.21e-05	0.000868	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.17e-05	0.000858	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GGCT—gestational diabetes	4.11e-05	0.000848	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.04e-05	0.000833	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—LEP—gestational diabetes	3.91e-05	0.000806	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP19A1—gestational diabetes	3.91e-05	0.000805	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NAMPT—gestational diabetes	3.67e-05	0.000757	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GCK—gestational diabetes	3.65e-05	0.000752	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GLS2—gestational diabetes	3.6e-05	0.000741	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LEP—gestational diabetes	3.43e-05	0.000707	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NAMPT—gestational diabetes	3.28e-05	0.000675	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GCK—gestational diabetes	3.26e-05	0.000671	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NAMPT—gestational diabetes	3.2e-05	0.000659	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GCK—gestational diabetes	3.18e-05	0.000655	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP19A1—gestational diabetes	3.08e-05	0.000635	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NAMPT—gestational diabetes	3.01e-05	0.000621	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GCK—gestational diabetes	3e-05	0.000617	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NAMPT—gestational diabetes	2.99e-05	0.000616	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FGF2—gestational diabetes	2.97e-05	0.000612	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GCK—gestational diabetes	2.97e-05	0.000612	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEP—gestational diabetes	2.9e-05	0.000597	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP19A1—gestational diabetes	2.67e-05	0.00055	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FGF2—gestational diabetes	2.6e-05	0.000537	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NAMPT—gestational diabetes	2.55e-05	0.000526	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GCK—gestational diabetes	2.54e-05	0.000523	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP19A1—gestational diabetes	2.38e-05	0.000491	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.32e-05	0.000479	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGF2—gestational diabetes	2.2e-05	0.000454	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP19A1—gestational diabetes	2.19e-05	0.000451	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP19A1—gestational diabetes	2.17e-05	0.000447	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.97e-05	0.000406	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCK—gestational diabetes	1.96e-05	0.000404	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP19A1—gestational diabetes	1.86e-05	0.000382	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.43e-05	0.000295	CbGpPWpGaD
